(Q36414853)

14 August 2017

1 reference

title

Improving the morbidity of anorectal injury from pelvic radiotherapy (English)

1 reference

adaptive radiation therapy

14 August 2017

main subject

0 references

author name string

Abbasakoor F

series ordinal

1

1 reference

14 August 2017

Vaizey CJ

series ordinal

2

1 reference

14 August 2017

Boulos PB

series ordinal

3

1 reference

14 August 2017

publication date

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

8

1 reference

14 August 2017

issue

1

1 reference

14 August 2017

page(s)

2-10

1 reference

Anorectal injury following pelvic radiotherapy

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2005.00851.X

Formalin instillation for refractory radiation-induced hemorrhagic proctitis. Report of 16 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2005.00851.X

Chronic effects of therapeutic irradiation for localized prostatic carcinoma on anorectal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2005.00851.X

Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2005.00851.X

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2005.00851.X

Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2005.00851.X

Acute morbidity reduction using 3DCRT for prostate carcinoma: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2005.00851.X

Contribution of conformal therapy in the treatment of anal canal carcinoma with combined chemotherapy and radiotherapy: results of a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2005.00851.X

High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2005.00851.X

Is tomotherapy the future of IMRT?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2005.00851.X

Hypofractionated conformal radiotherapy in carcinoma of the prostate: five-year outcome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2005.00851.X

Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2005.00851.X

Intrarectal application of amifostine for the prevention of radiation-induced rectal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2005.00851.X

Amifostine as radioprotective agent for the rectal mucosa during irradiation of pelvic tumors. A phase II randomized study using various toxicity scales and rectosigmoidoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2005.00851.X

Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: results of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2005.00851.X

A prospective randomized placebo-controlled double-blinded pilot study of misoprostol rectal suppositories in the prevention of acute and chronic radiation proctitis symptoms in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2005.00851.X

Diversion colitis in sigmoid neovagina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2005.00851.X

Physiologic changes of the anorectum after pelvic radiotherapy for the treatment of prostate and bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2005.00851.X

Prevention of irradiation-induced bowel discomfort by sucralfate: a double-blind, placebo-controlled study when treating localized pelvic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2005.00851.X

The effect of oral sucralfate on the acute proctitis associated with prostate radiotherapy: a double-blind, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2005.00851.X

A randomized double blind placebo controlled multicenter study of mesalazine for the prevention of acute radiation enteritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2005.00851.X

Olsalazine is contraindicated during pelvic radiation therapy: results of a double-blind, randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2005.00851.X

Phase III Double-Blind Study of Glutamine Versus Placebo for the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2005.00851.X

2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2005.00851.X

A phase III double-blind randomised study of rectal sucralfate suspension in the prevention of acute radiation proctitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2005.00851.X

10.1111/J.1463-1318.2005.00851.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference